The goal of this study was to elucidate radiologic biomarker that can predict the outcome of cochlear implantation (CI) in congenital cytomegalovirus (cCMV) related deafness. A retrospective survey of speech perception after CI and an evaluation of brain magnetic resonance imaging (MRI) findings were performed in 10 cochlear implantees with cCMV-related prelingual deafness. Specifically, a special attention was paid to the degree of white matter (WM) abnormality shown in brain MRI, which was used to divide our cohort into two groups: The mild and severe pathology groups. Age-matched prelingual deaf patients with idiopathic sensorineural hearing loss were selected as controls. Subjects in mild pathology groups showed higher a Category of Auditory Performance (CAP) score (5.2 ± 0.8) than those with severe pathologies (3.4 ± 1.5) (P = 0.041). Importantly, speech performance from subjects with mild pathology was comparable to that of the control group (mean CAP score of 5.2 ± 0.8 vs. 5.1 ± 1.2) (P = 0.898). Mild pathologies related to the limited WM lesion in MRI not accompanied by severe MRI pathologies, such as diffuse WM abnormality, myelination delay, ventriculomegaly, migration abnormality, and cerebellar hypoplasia, can be tolerated and do not adversely affect the CI outcome in cCMV deafness.
Noise-induced hearing loss (NIHL) is primarily caused by damage to cochlear hair cells, associated with synaptopathy. The novel cell-penetrating peptide GV1001, an antitumor agent, also has antioxidant and anti-inflammatory effects, and is otoprotective in a murine model of kanamycin-induced ototoxicity. Here, we explored whether GV1001 attenuated NIHL, and the underlying mechanism at play. We established an NIHL model by exposing 4- to 6-week-old C57/BL6 mice to white noise at 120 dB SPL for 2 h, resulting in a significant permanent threshold shift (PTS). We then subcutaneously injected saline (control), GV1001, or dexamethasone immediately after cessation of PTS-noise exposure and evaluated the threshold shifts, structural damages to outer hair cells (OHCs), and ribbon synapses. We also verified whether GV1001 attenuates oxidative stress at the level of lipid peroxidation or protein nitration in OHCs 1 h after exposure to white noise at 120 dB SPL. GV1001-treated mice exhibited significantly less hearing threshold shifts over 2 weeks and preserved OHCs and ribbon synapses compared with controls. Similarly, dexamethasone-treated mice showed comparable protection against NIHL. Importantly, GV1001 markedly attenuated oxidative stress in OHCs. Our findings suggest that GV1001 may protect against NIHL by lowering oxidative stress and may serve as preventive or adjuvant treatment.
1 September 2021 in The Journal of International Advanced Otology
OBJECTIVES: Prediction of cochlear implantation (CI) outcome is often difficult because outcomes vary among patients. Though the brain plasticity across modalities during deafness is associated with individual CI outcomes, longitudinal observations in multiple patients are scarce. Therefore, we sought a prediction system based on cross-modal plasticity in a longitudinal study with multiple patients. METHODS: Classification of CI outcomes between excellent or poor was tested based on the features of brain cross-modal plasticity, measured using event-related responses and their corresponding electromagnetic sources. A machine learning estimation model was applied to 13 datasets from 3 patients based on linear supervised training. Classification efficiency was evaluated comparing prediction accuracy, sensitivity/specificity, total mis-classification cost, and training time among feature set conditions. RESULTS: Combined feature sets with the sensor and source levels dramatically improved classification accuracy between excellent and poor outcomes. Specifically, the tactile feature set best explained CI outcome (accuracy, 98.83 ± 2.57%; sensitivity, 98.00 ± 0.01%; specificity, 98.15 ± 4.26%; total misclassification cost, 0.17 ± 0.38; training time, 0.51 ± 0.09 sec), followed by the visual feature (accuracy, 93.50 ± 4.89%; sensitivity, 89.17 ± 8.16%; specificity, 98.00 ± 0.01%; total misclassification cost, 0.65 ± 0.49; training time, 0.38 ± 0.50 sec). CONCLUSION: Individual tactile and visual processing in the brain best classified the current status when classified by combined sensor–source level features. Our results suggest that cross-modal brain plasticity due to deafness may provide a basis for classifying the status. We expect this novel method to contribute to the evaluation and prediction of CI outcomes. Cite this article as: Kyong J, Suh M, Joon Han J, et al. Cross-modal cortical activity in the brain can predict cochlear implantation outcome in adults: A machine learning study. J Int Adv Otol. 2021; 17(5): 380-386.
OBJECTIVES: The aim of this study was to evaluate the preoperative and postoperative facial nerve (FN) function in patients with FN schwannoma (FNS) and analyze the duration of preoperative facial palsy according to the preoperative and postoperative facial function. MATERIALS and METHODS: We retrospectively reviewed the medical records of 29 patients with FNS who underwent surgery. We evaluated the FN function according to the type of FN manipulation and location of the anastomoses in the cable nerve graft, and we also analyzed the duration of facial palsy according to the facial function before and after surgery. RESULTS: All 4 patients who underwent nerve-stripping surgery had the House–Brackmann (H-B) Grade III, 12 of 21 who underwent a cable nerve graft had the H-B Grade III or better postoperatively, and all 4 who underwent a hypoglossal facial crossover had the H-B Grade IV. Patients who underwent cable nerve grafting were more likely to have better FN function when the proximal anastomosis site was located in the internal auditory canal, geniculate ganglion, tympanic segment of FN, and distal end in the mastoid segment of FN. The duration of preoperative facial palsy was statistically shorter in patients with better postoperative facial function. CONCLUSION: Surgery can be considered in patients with FNS who have the H-B Grade III or worse. A shorter duration of facial palsy prior to surgery resulted in better postoperative facial function. Cite this article as: Kang WS, Han JJ, Rhee R, Lee JH, Koo JW, Chung JW. Surgical Outcomes of Intratemporal Facial Nerve Schwannomas According to Facial Nerve Manipulation. J Int Adv Otol 2019; 15(3): 415-9.
30 September 2021 in Journal of Clinical Otolaryngology